Indications & Dose:
Palliative and adjuvant to surgery and radiation therapy: Testicular tumour, squamous cell carcinoma of skin, neck and head, genitourinary tract and oesophagus neoplasm, malignancy of cervix. Hodgkin’s and non Hodgkin’s lymphoma. Chorio carcinoma and embroyo-nal cell carcinoma of testis. Brain tumour, glioma.
DOSE
Adults 30mg twice weekly in average cases, otherwise dose can be varied between 15mg daily to 15mg weekly. Total dose: 300-400mg. Small cell cancer 0.25mg-0.5mg/kg i.v, i.m, s.c. once or twice weekly. Hodgkin’s disease 0.25mg-0.5mg/kg i.v, i.m, s.c.
Contraindications:
Pregnancy & breastfeeding. Pre-existing pulmonary disease, hypersensitivity.
Side Effects:
Cerebrovascular accident stomatitis, interstitial pneumonitis, hyperthermia, & alopecia, hypertrophic skin changes & hyperpigmentation of hands.
Nausea, vomiting, fever, anaphylaxis, skin rash,Ranaud’s phenomenon, stomatitis, pulmonary fibrosis,Renal and hepatic toxicity.
Cautions:
Impaired renal & hepatic functions. Elderly patients.Patients who have received extensive treatment with bleomycin (e.g. cumulative dose more than 100 units) may be at risk of developing respiratory failure if a general anaesthetic is given with high inspired oxygen concentrations. Anaesthetists should be warned of this.
OLD AGE: Use with caution
Precautions:
Interaction:
Drugs
Digoxin: Decreased serum levels of digoxin.
Phenytoin: Decrease serum levels of phenytoin.
Radiotherapy: Enhanced toxicity.
O2 Therapy: Enhanced pulmonary toxicity.
Cisplatin: Toxicity increased by bleomycin.
Vincristine: Debilitation syndrome.
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team